In the pathogenesis of CRC, the EGFR signaling pathway is implicated in the promotion of tumor cell proliferation, migration, inhibition of apoptosis, angiogenesis, and immune evasion by tumor cells [43]. This evidence concerns the gene EGFR and colorectal carcinoma.